Knee Pain After 50: When Physical Therapy Isn’t Enough and What to Try Next

You’ve been doing the exercises. You’ve tried the anti-inflammatories. You’ve gone to physical therapy—maybe two or three rounds. And your knee still hurts.

If you’re over 50 and dealing with knee osteoarthritis, this is one of the most frustrating places to be. Your primary care doctor tells you to “keep doing PT.” Your orthopedic surgeon says you’re “not bad enough yet” for knee replacement. And you’re left in a treatment gap with no clear next step—just the slow, grinding reality of a knee that limits what you can do.

You’re not alone. An estimated 3.6 million Americans fall into this gap between conservative therapy and joint replacement every year. And until recently, there weren’t many good options to fill it.

That’s changing. In this article, we’ll walk through the bridge treatments available for knee osteoarthritis—from injections to newer interventional procedures—and explain where each one fits based on the current evidence. At Surgical Associates (SACMD), Dr. Albert Chun specializes in genicular artery embolization (GAE), the newest entry in this space, and we’ll explain why it’s generating significant attention in the interventional radiology and orthopedic communities.

The Treatment Gap, Explained

Here’s the typical trajectory for knee osteoarthritis after 50:

Stage 1: Conservative management. Your doctor recommends weight management, over-the-counter pain relievers (acetaminophen, NSAIDs like ibuprofen), activity modification, and physical therapy. For many patients, this provides adequate relief for months or years.

Stage 2: The gap. Conservative measures stop working. Your pain worsens. You’re avoiding activities you love—hiking, gardening, playing with grandchildren, even walking through the grocery store. Your doctor offers cortisone injections, which help for a few weeks or months, then wear off. You try again. They work less each time.

Stage 3: Joint replacement. When pain becomes constant and function is severely limited, total knee replacement (TKR) is recommended. It’s effective—but it’s major surgery with a 3-to-6-month recovery, real risks (infection, blood clots, stiffness), and a prosthetic that will eventually need revision.

The problem is that many patients are stuck in Stage 2 for years, sometimes decades. They’re suffering, but they’re told they’re “not ready” for surgery. Or they are ready but don’t want to be—they’re too active, too young, or too wary of the risks.

This gap is where bridge treatments live. Let’s examine each one.

The Bridge Options: A Comparison

Cortisone Injections

How they work: Corticosteroid injections deliver a powerful anti-inflammatory directly into the knee joint, temporarily reducing inflammation and pain.

What the evidence shows: Most patients experience significant relief for 4 to 12 weeks. Some patients can repeat injections every 3–6 months, though guidelines generally limit frequency. There is evidence that repeated cortisone injections may accelerate cartilage loss over time, which has led some orthopedic surgeons to use them more cautiously.

Best for: Flare-ups and short-term relief while pursuing other treatments or preparing for surgery.

Limitations: Temporary. Diminishing returns with repeated use. Potential long-term cartilage effects.

Viscosupplementation (Hyaluronic Acid Injections)

How it works: A gel-like substance (hyaluronic acid) is injected into the knee joint to supplement the natural joint fluid, theoretically improving lubrication and cushioning.

What the evidence shows: Results are mixed. Some patients report meaningful improvement, while systematic reviews and meta-analyses have questioned whether the benefit exceeds placebo. The 2024 ACC/AHA guideline does not include a strong recommendation for viscosupplementation. Insurance coverage varies.

Best for: Patients with mild-to-moderate OA who want a non-surgical option and are willing to try a series of injections (typically 3–5 over several weeks).

Limitations: Uncertain evidence base. Multiple injection sessions required. Benefits, when present, are typically modest and temporary.

Platelet-Rich Plasma (PRP)

How it works: A sample of your own blood is drawn, processed in a centrifuge to concentrate the platelets, and injected into the knee. The concentrated growth factors are theorized to promote tissue healing and reduce inflammation.

What the evidence shows: Some studies show improvement in pain and function, particularly compared to hyaluronic acid injections. However, PRP protocols vary widely (single vs. double spin, leukocyte-rich vs. leukocyte-poor), making it difficult to compare across studies. PRP is not FDA-approved specifically for knee OA, and it is typically not covered by insurance.

Best for: Patients willing to pay out-of-pocket for a biologic therapy with some supporting evidence but significant variability in outcomes.

Limitations: Not standardized. Not covered by most insurance. Evidence is promising but not definitive.

Genicular Nerve Blocks and Radiofrequency Ablation

How they work: Genicular nerve blocks use local anesthetic injections to temporarily numb the sensory nerves around the knee. If the block provides relief, radiofrequency ablation (RFA) can be used to create longer-lasting disruption of those pain signals by heating the nerves.

What the evidence shows: Several studies have demonstrated significant pain relief lasting 6–12 months after genicular nerve RFA. It’s a reasonable option for patients who respond to the diagnostic nerve block.

Best for: Patients with knee OA pain who are not surgical candidates and who get clear relief from the diagnostic nerve block.

Limitations: Targets pain signals, not the underlying inflammatory process. Nerves can regenerate over time, requiring repeat procedures. Does not address the source of inflammation.

Genicular Artery Embolization (GAE)

How it works: GAE is a catheter-based procedure that targets the abnormal blood vessels (neovascularity) that develop in the inflamed synovial lining of an osteoarthritic knee. These abnormal vessels bring inflammatory cells and nerve fibers into the joint, driving both inflammation and pain. By selectively embolizing these vessels with tiny microspheres, GAE reduces the inflammatory process at its vascular source.

What the evidence shows: This is where GAE distinguishes itself from other bridge treatments. A prospective trial published on ScienceDirect demonstrated a 55.4% reduction in VAS pain scores at 12 months (P < .001). The multicenter sham-controlled RCT (Bagla et al., JVIR 2022) confirmed that GAE provides pain relief beyond the placebo effect. A 2-year IDE trial from UCLA showed that 72% of initial responders maintained clinical success at 24 months. And a meta-analysis of 270 patients across 9 studies found significant, clinically meaningful improvements at every follow-up interval.

An important distinction: GAE does not regrow cartilage. It does not reverse structural joint damage. What it does is reduce the inflammation-driven component of pain, which, in many patients with mild-to-moderate OA, is the dominant driver of their symptoms. Patients whose pain is primarily caused by bone-on-bone contact in a severely damaged joint are unlikely to benefit and should consider joint replacement.

Best for: Mild-to-moderate OA (Kellgren-Lawrence grade 2–3). Patients who have failed conservative therapy but are not ready for or interested in knee replacement. Patients who want to preserve their native joint.

Limitations: Does not address structural cartilage loss. Not appropriate for severe, end-stage OA. Still a relatively new procedure with evolving long-term data (though 2-year results are encouraging).

How to Decide: A Framework

The right treatment depends on your specific situation—your OA severity, your symptoms, your goals, and your risk tolerance. Here’s a practical decision framework:

If your pain is intermittent and manageable most days, continue with conservative management. Optimize your physical therapy, maintain a healthy weight, and use NSAIDs as needed. You’re not in the gap yet.

If conservative management isn’t working but your X-rays show mild-to-moderate OA, consider GAE. This is the sweet spot where the procedure has the strongest evidence and the most to offer. The inflammation driving your pain can be directly addressed without surgery, and you preserve all future options.

If you need short-term relief for a specific event or flare, a cortisone injection is reasonable as a bridge while you evaluate other options. Just be aware of the potential for diminishing returns.

If your X-rays show severe, bone-on-bone OA with significant structural damage, and your function is substantially limited, total knee replacement is likely the most appropriate path. GAE is not a substitute for joint replacement when the joint is severely degraded.

If you’ve already had a knee replacement and still have pain, don’t assume nothing can be done. Emerging research shows that GAE can help patients with persistent pain after total knee arthroplasty who have no evidence of prosthetic loosening or infection.

GAE at SACMD: Serving Maryland, DC, and Virginia

Dr. Albert Chun performs GAE at Surgical Associates’ locations, including the Reston, Virginia office—making this treatment accessible to patients throughout Northern Virginia, the DC metro area, and Southern Maryland.

The procedure takes approximately 60–90 minutes, is performed under local anesthesia with light sedation, and patients go home the same day. Most return to daily activities within 2–3 days. Pain relief typically begins building within weeks and continues to improve over 1–3 months as the inflammatory response diminishes.

GAE is increasingly covered by insurance, including Medicare, when performed as a medically necessary procedure for refractory knee OA pain.

The Bottom Line

If you’re over 50 with knee osteoarthritis and you’ve been told your only options are “more Advil” or “knee replacement,” the reality is more nuanced than that. Several bridge treatments exist, and among them, GAE stands out as the option with the strongest and most rapidly growing evidence base for durable, clinically meaningful pain relief.

It’s not a cure for arthritis. It won’t regrow your cartilage. But for the right patient—one whose pain is driven by inflammation in a joint that still has structural integrity—it can be the difference between years of unnecessary suffering and a return to the activities that matter to you.

Schedule a consultation: Call (240) 427-1630 or visit www.sacmd.com

Related reading on SACMD:


Disclaimer: This article is for informational purposes only and does not constitute medical advice. Individual results vary. Consult with a qualified physician to determine which treatment approach is appropriate for your condition.

References:

  1. Taslakian B, et al. A Prospective Single-Arm Trial of Genicular Artery Embolization for Symptomatic Knee Osteoarthritis. J Vasc Interv Radiol. 2025.
  2. Bagla S, et al. Multicenter Randomized Sham Controlled Study of Genicular Artery Embolization. J Vasc Interv Radiol. 2022;33(1):2-10.
  3. Cusumano LR, et al. Genicular Artery Embolization for Treatment of Symptomatic Knee Osteoarthritis: 2-Year Outcomes. J Vasc Interv Radiol. 2024;35(12):1768-1775.
  4. Genicular artery embolization for treatment of knee osteoarthritis pain: Systematic review and meta-analysis. 2023.
  5. Gornik HL, et al. 2024 ACC/AHA/Multisociety Guideline for Lower Extremity PAD. J Am Coll Cardiol. 2024;83(24):2497-2604.